Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$10.52 - $20.68 $1.51 Million - $2.98 Million
-143,946 Reduced 30.16%
333,279 $3.63 Million
Q2 2023

Aug 14, 2023

SELL
$17.18 - $23.76 $1.19 Million - $1.64 Million
-68,985 Reduced 12.63%
477,225 $10.4 Million
Q1 2023

May 12, 2023

BUY
$18.25 - $30.26 $1.2 Million - $1.99 Million
65,804 Added 13.7%
546,210 $10.1 Million
Q4 2022

Feb 14, 2023

SELL
$12.36 - $26.41 $2.43 Million - $5.2 Million
-196,959 Reduced 29.08%
480,406 $12.4 Million
Q3 2022

Nov 14, 2022

BUY
$14.67 - $21.7 $6.16 Million - $9.12 Million
420,142 Added 163.34%
677,365 $10.8 Million
Q2 2022

Aug 12, 2022

BUY
$13.46 - $48.16 $3.46 Million - $12.4 Million
257,223 New
257,223 $3.82 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $54.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Next Century Growth Investors LLC Portfolio

Follow Next Century Growth Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Century Growth Investors LLC with notifications on news.